Analysis of the Austrian market for opacifying preparations for X-ray and diagnostic reagents reveals a gradual decline in value per capita over the decade up to 2023. In 2023, this value stood at $6.83 per capita, reflecting a modest but steady downward trend. The year-on-year variation from 2022 to 2023 is a slight decrease of 0.44%. Over the past five years, this segment has experienced an approximate Compound Annual Growth Rate (CAGR) of -1.36%.
Looking forward, key trends to watch include technological advancements in diagnostic imaging, potential shifts towards digital solutions, and changes in healthcare policies that may impact market dynamics. Continued emphasis on cost-efficiency and innovation will likely shape future growth patterns.
| # | 24 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 9.87 | 2023 | View data | ||
| 2 | 2 Italy | 9.66 | 2023 | View data | ||
| 3 | 3 Greece | 8.33 | 2023 | View data | ||
| 4 | 4 Australia | 7.28 | 2023 | View data | ||
| 5 | 5 Austria | 6.83 | 2023 | |||
| 6 | 6 Canada | 6.42 | 2023 | View data | ||
| 7 | 7 Slovakia | 5.92 | 2023 | View data | ||
